Complement 1
PrivateLast Round
Seed
May 13, 2025
Est. Valuation
$60M
Total Funding Raised
$16M
Company Overview
Complement 1 is a health technology company that provides a tech-enabled, clinically validated lifestyle modification platform with one-on-one coaching for cancer patients and high-risk individuals.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Medical AI, Telemedicine, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Complement 1 Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Complement 1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2025 |
Key People
Founding team and executive leadership
Complement 1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Owl Ventures | Seed |
| Blume Ventures | Seed |
| Owl Ventures | Seed |
Complement 1 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Complement 1's valuation, stock price, and market status.